[Neuroendocrine activation in heart failure I. Pathophysiology and pharmacological intervention]
- PMID: 11094549
[Neuroendocrine activation in heart failure I. Pathophysiology and pharmacological intervention]
Abstract
The important neuroendocrine systems implicated in heart failure are reviewed here, with special emphasis on their possible role in pathophysiology and the chances of pharmacological intervention. The part played by the sympathetic nervous system and the renin-angiotensin-aldosterone system and the beneficial effects of beta-blockers, ACE inhibitors, and angiotensin II antagonists are well-established. The involvement of vasopressin, endothelin-1, ANP, BNP, and TNF-alpha and the interventional possibilities relating to these hormones are also discussed. It is concluded that, in addition to the known interventional principles of neuroendocrine activation, there is a series of new exciting principles and some of them might become important in the future.
Similar articles
-
Heart failure and neuroendocrine activation: diagnostic, prognostic and therapeutic perspectives.Clin Physiol. 2001 Nov;21(6):661-72. doi: 10.1046/j.1365-2281.2001.00371.x. Clin Physiol. 2001. PMID: 11722473 Review.
-
[Neurohumoral mechanisms in pathophysiology of chronic heart failure].Przegl Lek. 2000;57(12):750-6. Przegl Lek. 2000. PMID: 11398602 Review. Polish.
-
Neuroendocrine activation as a target of modern chronic heart failure pharmacotherapy.Acta Pol Pharm. 2011 May-Jun;68(3):307-16. Acta Pol Pharm. 2011. PMID: 21648184 Review.
-
[Neuro-hormonal mechanisms in heart failure -- from physiopathology to treatment].Rev Port Cardiol. 2001 May;20 Suppl 5:V-99-122; discussion V-123-5. Rev Port Cardiol. 2001. PMID: 11515306 Review. Portuguese.
-
Pathophysiology and clinical spectrum of acute congestive heart failure.Rev Cardiovasc Med. 2001;2 Suppl 2:S2-6. Rev Cardiovasc Med. 2001. PMID: 12439355 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical
Miscellaneous